(Q37884431)

24 August 2017

1 reference

title

Recent developments in doping testing for erythropoietin (English)

1 reference

24 August 2017

1 reference

Christian Reichel

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

3 June 2011

1 reference

Analytical and Bioanalytical Chemistry

24 August 2017

number of pages

19

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 August 2017

volume

401

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

463-481

1 reference

https://scigraph.springernature.com/pub.10.1007/s00216-011-5116-y

24 August 2017

exact match

0 references

cites work

Cloning and expression of the human erythropoietin gene

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Molecular charge heterogeneity of human serum erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Comparisons of human, rat and mouse erythropoietins by isoelectric focusing: differences between serum and urinary erythropoietins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Rapid affinity purification of erythropoietin from biological samples using disposable monoliths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Quantitative analysis of images in erythropoietin doping control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

GASepo-a software solution for quantitative analysis of digital images in Epo doping control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Improvement of band segmentation in Epo images via column shift transformation with cost functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Procedures for monitoring recombinant erythropoietin and analogues in doping control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Clarification on the detection of epoetin delta and epoetin omega using isoelectric focusing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

No doubt about the validity of the urine test for detection of recombinant human erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Non-specific binding of monoclonal human erythropoietin antibody AE7A5 to Escherichia coli and Saccharomyces cerevisiae proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

False-positive Epo test concerns unfounded.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

IEF pattern classification-derived criteria for the identification of epoetin-delta in urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

The interference of heparin on IEF-PAGE of erythropoietins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Defending Dynepo detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Epoetin alpha, epoetin beta and darbepoetin alfa: two-dimensional gel electrophoresis isoforms characterization and mass spectrometry analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Evaluation of protein N-glycosylation in 2-DE: Erythropoietin as a study case

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

A new principle suggested for detection of darbepoetin-alpha (NESP) doping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Development and characterization of novel erythropoiesis stimulating protein (NESP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Anti-EPO and anti-NESP antibodies raised against synthetic peptides that reproduce the minimal amino acid sequence differences between EPO and NESP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

A protocol to guide development of a sensitive ELISA for canine erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Purification of erythropoietin from human plasma samples using an immunoaffinity well plate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

A rapid and simple assay to determine pegylated erythropoietin in human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

A high-throughput test to detect C.E.R.A. doping in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Lab-on-a-chip technology for determination of protein isoform profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Ultra-sensitive immunochromatographic assay for quantitative determination of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Lectin affinity chromatography as a tool to differentiate endogenous and recombinant erythropoietins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Physicochemical and biological characterization of asialoerythropoietin. Suppressive effects of sialic acid in the expression of biological activity of human erythropoietin in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Proteolysis and autolysis of proteases and the detection of degradation products in doping control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Detection of the protease bacillolysin in doping-control urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Glycopeptide profiling of human urinary erythropoietin by matrix-assisted laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Microheterogeneity of erythropoietin carbohydrate structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Identification and structural characterization of a mannose-6-phosphate containing oligomannosidic N-glycan from human erythropoietin secreted by recombinant BHK-21 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Structural analysis of sulfated N-linked oligosaccharides in erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Usefulness of sugar mapping by liquid chromatography/mass spectrometry in comparability assessments of glycoprotein products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Usefulness of glycopeptide mapping by liquid chromatography/mass spectrometry in comparability assessment of glycoprotein products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

LC-MS/MS method for confirmation of recombinant human erythropoietin and darbepoetin alpha in equine plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Differentiation and identification of recombinant human erythropoietin and darbepoetin Alfa in equine plasma by LC-MS/MS for doping control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Confirmatory analysis of continuous erythropoietin receptor activator and erythropoietin analogues in equine plasma by LC-MS for doping control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Small peptides as potent mimetics of the protein hormone erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Hematopoietic growth factor mimetics: from concept to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Emerging drugs: mechanism of action, mass spectrometry and doping control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

The hunt for gene dopers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Gene doping: of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

“Genetic Doping” with erythropoietin cDNA in primate muscle is detectable

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Detection of recombinant human erythropoietin in urine for doping analysis: Interpretation of isoelectric profiles by discriminant analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Pitfalls, errors and risks of false-positive results in urinary EPO drug tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

Recombinant erythropoietin in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5116-Y

10.1007/S00216-011-5116-Y

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference